Clinical Education Center

Knowledge of an inflammatory biomarker of cardiovascular risk leads to biomarker-based decreased risk in pre-diabetic and diabetic patients.

Authors: Alcivar-Franco D, Purvis S, Penn MS, Klemes A
J Int Med Res. 2020 Jan;48(1):300060517749111. doi: 10.1177/0300060517749111.

Specialties: Cardiology, Endocrinology, Diabetes & Metabolism

Disclaimer: One or more of the authors of this publication were employed at the time by Cleveland HeartLab, a subsidiary of Quest Diagnostics.

Outreach and Connection to Care for Chronic Kidney Disease in a Workplace Wellness Setting: A Cost-Effectiveness Analysis.

Authors: Li Y, Devlin JJ.
Popul Health Manag. 2020 Jan 2. doi: 10.1089/pop.2019.0206. [Epub ahead of print].

Specialties: Cardiology, Endocrinology, Diabetes & Metabolism

Read the Key Summary (Download PDF)

Electrokinetic Mixing for Improving the Kinetics of an HbA1c Immunoassay.

Authors: Yasun E, Trusty T, Abolhosn RW, Clarke NJ, Mezić I.
Sci Rep. 2019 Dec 27;9(1):19885.

Specialties: Cardiology, Endocrinology, Diabetes & Metabolism

Free thyroxine concentrations in sera of individuals with Familial Dysalbuminemic Hyperthyroxinemia: a comparison of three methods of measurement.

Authors: Refetoff S, Scherberg N, Yuan C, Wu W, Wu Z, McPhaul MJ.
Thyroid. 2019 Dec 10. doi: 10.1089/thy.2019.0058. [Epub ahead of print]

Specialties: Cardiology, Endocrinology, Diabetes & Metabolism

Perspectives on the Changing Landscape of Measuring Cardiovascular Risk Related to LDL.

Authors: El-Khoury JM, Remaley AT, Nordestgaard BG, Kaufman HW, Mora S, Cao J, Meeusen JW.
Clin Chem. 2019 Dec;65(12):1487-1492.

Specialties: Cardiology, Endocrinology, Diabetes & Metabolism

Serum 25-hydroxyvitamin D in the VITamin D and OmegA-3 TriaL (VITAL): Clinical and demographic characteristics associated with baseline and change with randomized vitamin D treatment.

Authors: Luttmann-Gibson H, Mora S, Camargo CA, Cook NR, Demler OV, Ghoshal A, Wohlgemuth J, Kulkarni K, Larsen J, Prentice J, Cobble M, Bubes V, Li C, Friedenberg G, Lee IM, Buring JE, Manson JE.
Contemp Clin Trials. 2019 Dec;87:105854.

Specialties: Cardiology, Endocrinology, Diabetes & Metabolism

Read the Key Summary (Download PDF)

Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes.

Authors: Bril F, McPhaul MJ, Caulfield MP, Clark VC, Soldevilla-Pico C, Firpi-Morell RJ, Lai J, Shiffman D, Rowland CM, Cusi K.
Diabetes Care 2019 Oct 11. doi: 10.2337/dc19-1071. [Epub ahead of print]

Specialties: Cardiology, Endocrinology, Diabetes & Metabolism, Gastroenterology, Internal Medicine

Association between polymorphisms of LEP, LEPR, DRD2, HTR2A and HTR2C genes and risperidone- or clozapine-induced hyperglycemia.

Authors: Puangpetch A, Srisawasdi P, Unaharassamee W, Jiratjintana N, Vanavanan S, Punprasit S, Na Nakorn C, Sukasem C, Kroll MH
Pharmgenomics Pers Med. 2019 Aug 6;12:155-166.

Specialties: Cardiology, Endocrinology, Diabetes & Metabolism

Increasing metabolic co-morbidities are associated with higher risk of advanced fibrosis in nonalcoholic steatohepatitis.

Authors: Wong RJ, Tran T, Kaufman H, Niles J, Gish R.
PLoS One. 2019 Aug 1;14(8):e0220612.

Specialties: Cardiology, Endocrinology, Diabetes & Metabolism

Read the Key Summary (Download PDF)

Pancreatic neuroendocrine microadenomatosis presenting as a functional VIPoma.

Authors: Krainev AA, Mathavan VK, Klink DF, Saxe JM, Ong GKB, Murphy JK.
J Surg Case Rep. 2019 Jun 28;2019(6):rjz196.

Specialties: Dermatology, Endocrinology, Diabetes & Metabolism, Gastroenterology, Oncology

Disclaimer: One or more of the authors of this publication were employed at the time by AmeriPath, a subsidiary of Quest Diagnostics.